Medroxyprogesterone is a synthetic progestin derived from progesterone via 6α-methylation and 17α-hydroxylation, featuring a 3-oxo-Δ4-pregnene core with a 17-hydroxyl group and a 6-methyl substituent. The compound exhibits enhanced metabolic stability relative to progesterone due to steric hindrance at C6 and hydrogen bonding capacity at C17. Its polarity is modulated by the hydroxyl group, enabling lipid-soluble delivery. It functions as an active pharmaceutical ingredient in the formulation of progestin-based therapeutic agents.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1378023 ↗ | 25 mg | USD 948.00 |
C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C
InChI=1S/C22H32O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h12-13,16-18,25H,5-11H2,1-4H3/t13-,16+,17-,18-,20+,21-,22-/m0/s1
FRQMUZJSZHZSGN-HBNHAYAOSA-N